Net Cash Provided by (Used in) Financing Activities in USD of Elevance Health, Inc. from Q1 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Elevance Health, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2010 to Q1 2025.
  • Elevance Health, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$1.91B, a 6066% decline year-over-year.
  • Elevance Health, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $1.19B.
  • Elevance Health, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$3.35B, a 154% decline from 2022.
  • Elevance Health, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$1.32B, a 412% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

Elevance Health, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$1.91B -$1.94B -6066% Jan 1, 2025 Mar 31, 2025 10-Q 2025-04-22
Q1 2024 $32M +$563M Jan 1, 2024 Mar 31, 2024 10-Q 2025-04-22
Q1 2023 -$531M -$853M -265% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-18
Q1 2022 $322M -$3.07B -90.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-19
Q1 2021 $3.39B +$2.71B +399% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-20
Q1 2020 $679M +$1.11B Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-21
Q1 2019 -$429M +$198M +31.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q1 2018 -$627M -$1.86B -151% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-24
Q1 2017 $1.23B +$1.64B Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-25
Q1 2016 -$409M -$721M -231% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-26
Q1 2015 $312M +$571M Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-27
Q1 2014 -$259M +$321M +55.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-29
Q1 2013 -$579M +$588M +50.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-30
Q1 2012 -$1.17B -$381M -48.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-24
Q1 2011 -$786M +$372M +32.1% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-25
Q1 2010 -$1.16B Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-27

Elevance Health, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.19B +$4.54B Jan 1, 2024 Dec 31, 2024 10-K 2025-02-20
2023 -$3.35B -$2.03B -154% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-20
2022 -$1.32B -$1.74B -412% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-20
2021 $423M +$2.99B Jan 1, 2021 Dec 31, 2021 10-K 2024-02-21
2020 -$2.57B -$301M -13.3% Jan 1, 2020 Dec 31, 2020 10-Q 2023-10-18
2019 -$2.27B -$25M -1.12% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-16
2018 -$2.24B -$2.67B -625% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-18
2017 $427M +$1.23B Jan 1, 2017 Dec 31, 2017 10-K 2020-02-19
2016 -$799M +$2.29B +74.2% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-20
2015 -$3.09B -$1.27B -69.7% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-21
2014 -$1.82B -$105M -6.1% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-22
2013 -$1.72B -$3.81B -182% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-19
2012 $2.09B +$4.11B Jan 1, 2012 Dec 31, 2012 10-K 2015-02-24
2011 -$2.02B +$1.15B +36.3% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-20
2010 -$3.17B Jan 1, 2010 Dec 31, 2010 10-K 2013-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.